GM PHARMA’s manufacturing site in Tbilisi is the largest pharmaceutical plant in the Caucasus region, where the full manufacturing cycle is carried out through the newest technologies – from raw materials to the finished product. The basic formulation processes currently carried out in the factory are Blending, Granulation, Tableting, Tablet coating, Capsule filling, Bottle filling, Sachet filling and Blister and Bottle packaging. The company holds international certificates, permits, and licenses required for pharmaceutical manufacturing, such as: Good Manufacturing Practice – National GMP (Georgia), Quality Management – ISO 9001:2015 and ISO 17025:2017/2018, Good Manufacturing Practice – GMP PIC/S (International), as well as, US Dietary Supplement Safety Inspection (NSF International) – NSF/ANSI.

GM PHARMA is constantly monitored by independent auditors from the United Kingdom, the United States, and the European Union.

RESEARCH & DEVELOPMENT

In 2018, a new certified Research and Development Laboratory was established in GM PHARMA, which includes Process Development and Maintenance Laboratory (Technological Laboratory) and Analytical Development Laboratory. The Technological Laboratory is designed and fully equipped with modern laboratory-scale production equipment, which allows us to work on new dosage forms of medicinal products, innovative combinations and polypills.
GM PHARMA actively cooperates with European scientific and research centers and uses their experience in the production of its products.
In cooperation with European scientific centers, GM PHARMA aims to produce innovative combinations of drug products in Georgia.